FDA Inspection 755260 — Jilin Shulan Synthetic Pharmaceutical Co. Ltd.
The FDA completed an inspection of Jilin Shulan Synthetic Pharmaceutical Co. Ltd. on November 30, 2011 in Jilin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 30, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jilin (China)